Drugs / TIV
last change Apr 2014 re-read 3 minutes ago

TIV

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · The Emmes Company, LLC

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01676402 Aug 2012 → Apr 2014 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT01676402 ↗
Modality Vaccine “2012/13, 2013/14 Seasonal Influenza Trivalent Inactivated Vaccine (TIV)” NCT01676402 ↗